Eagle Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-232,113
Closed -$8.58M 585
2023
Q4
$8.58M Sell
232,113
-343,091
-60% -$12.9M 0.05% 295
2023
Q3
$22M Sell
575,204
-11,869
-2% -$486K 0.13% 168
2023
Q2
$21.2M Sell
587,073
-211,289
-26% -$7.21M 0.12% 174
2023
Q1
$30.5M Sell
798,362
-271,629
-25% -$12.7M 0.18% 141
2022
Q4
$59M Sell
1,069,991
-255,028
-19% -$13.1M 0.36% 106
2022
Q3
$52.4M Sell
1,325,019
-69,718
-5% -$3.08M 0.34% 105
2022
Q2
$61.4M Buy
1,394,737
+196,630
+16% +$8.5M 0.38% 99
2022
Q1
$47.8M Sell
1,198,107
-58,435
-5% -$2.08M 0.24% 131
2021
Q4
$50.7M Sell
1,256,542
-210,546
-14% -$7.86M 0.22% 147
2021
Q3
$59.7M Sell
1,467,088
-230,454
-14% -$9.63M 0.27% 140
2021
Q2
$77.1M Sell
1,697,542
-74,458
-4% -$3.3M 0.33% 116
2021
Q1
$75.2M Sell
1,772,000
-88,706
-5% -$4.05M 0.33% 118
2020
Q4
$79.5M Sell
1,860,706
-278,015
-13% -$9.99M 0.45% 68
2020
Q3
$56.7M Buy
2,138,721
+27,850
+1% +$776K 0.29% 129
2020
Q2
$54.5M Sell
2,110,871
-2,917
-0.1% -$65.8K 0.31% 128
2020
Q1
$38M Buy
2,113,788
+581,647
+38% +$11M 0.24% 155
2019
Q4
$27.2M Sell
1,532,141
-8,475
-0.6% -$147K 0.13% 214
2019
Q3
$23.9M Buy
+1,540,616
New +$25.4M 0.12% 217

Other funds holding HALO

Eagle Asset Management's HALO Position: Q1 2024 in Review

Eagle Asset Management sold out of Halozyme (HALO) in Q1 2024, closing a stake of 232,113 shares — an estimated $8.58M sold.

Eagle Asset Management first reported a position in HALO in Q3 2019 and held it in 18 quarters. The position peaked at $79.5M in Q4 2020. 414 funds tracked by Wall St. Rank hold HALO as of Q1 2024.

  • Eagle Asset Management reported no remaining Halozyme position as of Q1 2024 after selling out during the quarter.
  • Eagle Asset Management sold 232,113 Halozyme shares in Q1 2024, an estimated $8.58M.
  • Eagle Asset Management first reported a position in Halozyme in Q3 2019 and held it in 18 quarters.
  • Eagle Asset Management's Halozyme position peaked at $79.5M in Q4 2020.
  • 414 funds tracked by Wall St. Rank held Halozyme as of Q1 2024.

Based on Eagle Asset Management's 13F filing for Q1 2024, filed 9 May 2024.